Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)



Status:Completed
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - 80
Updated:4/21/2016
Start Date:March 2011
End Date:May 2013

Use our guide to learn which trials are right for you!

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy

This study is designed to evaluate the effectiveness of adding etanercept to disease
modifying anti-rheumatic drug (DMARD) therapy in patients with moderately active Rheumatoid
Arthritis (RA).


Inclusion Criteria:

- Male or female ≥18 and ≤80 years of age at time of screening

- Diagnosed with rheumatoid arthritis as determined by meeting 1987 American College of
Rheumatology (ACR) classification criteria and has had rheumatoid arthritis for at
least 6 months

- Moderate rheumatoid arthritis during screening, as defined by a disease activity
score (28 joint) calculated using the C-reactive protein formula (DAS28-CRP) > 3.2
and ≤ 5.1

- Active rheumatoid arthritis defined as ≥ 3 swollen joints (out of 28 joints examined)
and ≥ 3 tender/painful joints (out of 28 joints examined) at screening and baseline.
(A full 66/68 count joint count will be performed at baseline, but only joints in the
28-count joint count will be considered for eligibility. The 28-joint count consists
of the finger joints excluding the distal interphalangeal joints, the wrists, elbows,
shoulders, and knees)

- Must be currently taking a DMARD such as methotrexate, sulfasalazine, leflunomide,
minocycline, and/or hydroxychloroquine

Exclusion Criteria:

- Prosthetic joint infection within 5 years of screening or native joint infection
within 1 year of screening

- Class IV rheumatoid arthritis according to ACR revised response criteria

- Any active infection (including chronic or localized infections) for which
anti-infectives were indicated within 28 days prior to first investigational product
dose

- Previously used more than one experimental biologic DMARD. Patient with prior use of
no more than one experimental biologic is permitted if the subject received no more
than 8 weeks of treatment. The use of the experimental biologic must not have
occurred within 2 months of the first dose of investigational product

- Previously used more than one commercially available biologic DMARD. Subject with
prior use of no more than one commercially available biologic is permitted if the
patient received no more than 8 weeks of treatment and did not discontinue because of
lack of effect. The use of the biologic must not have occurred within 2 months of the
first dose of investigational product. Acceptable prior use of biologics include the
following examples:

- No more than 4 injections of adalimumab

- No more than 8 (50 mg) injections of etanercept

- No more than 2 infusions of infliximab

- No more than 2 infusions of abatacept

- Additional inclusion (exclusion) criteria may apply
We found this trial at
38
sites
?
mi
from
Greer, SC
Click here to add this to my saved trials
?
mi
from
Akron, OH
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
?
mi
from
Chesapeake, VA
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Denver, CO
Click here to add this to my saved trials
?
mi
from
Encino, CA
Click here to add this to my saved trials
?
mi
from
Erie, PA
Click here to add this to my saved trials
?
mi
from
Frederick, MD
Click here to add this to my saved trials
?
mi
from
Hemet, CA
Click here to add this to my saved trials
?
mi
from
Inglewood, CA
Click here to add this to my saved trials
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
?
mi
from
Lansing, MI
Click here to add this to my saved trials
?
mi
from
Lexington, KY
Click here to add this to my saved trials
?
mi
from
Mayfield Village, OH
Click here to add this to my saved trials
?
mi
from
Meridian, ID
Click here to add this to my saved trials
?
mi
from
Murrieta, CA
Click here to add this to my saved trials
?
mi
from
Ocala, FL
Click here to add this to my saved trials
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Peoria, AZ
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
Santa Maria, CA
Click here to add this to my saved trials
?
mi
from
Sarasota, FL
Click here to add this to my saved trials
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Sebring, FL
Click here to add this to my saved trials
?
mi
from
Springfield, IL
Click here to add this to my saved trials
?
mi
from
St. Clair Shores, MI
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
?
mi
from
Tustin, CA
Click here to add this to my saved trials
?
mi
from
Upland, CA
Click here to add this to my saved trials
?
mi
from
Victorville, CA
Click here to add this to my saved trials
?
mi
from
Winnipeg,
Click here to add this to my saved trials